Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Jeong Woo Kim
Young-Sun Lee
Yang Shin Park
Baek-Hui Kim
Soo Yeon Lee
Jong Eun Yeon
Chang Hee Lee
机构
[1] Korea University Guro Hospital,Department of Radiology
[2] Korea University College of Medicine,Department of Radiology
[3] Korean Armed Forces Capital Hospital,Department of Internal Medicine
[4] Korea University Guro Hospital,Department of Pathology
[5] Korea University College of Medicine,undefined
[6] Korea University Guro Hospital,undefined
[7] Korea University College of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic steatohepatitis (NASH) is a complex disease consisting of various components including steatosis, lobular inflammation, and ballooning degeneration, with or without fibrosis. Therefore, it is difficult to diagnose NASH with only one imaging modality. This study was aimed to evaluate the feasibility of magnetic resonance imaging (MRI) for predicting NASH and to develop a non-invasive multiparametric MR index for the detection of NASH in non-alcoholic fatty liver disease (NAFLD) patients. This prospective study included 47 NAFLD patients who were scheduled to undergo or underwent ultrasound-guided liver biopsy within 2 months. Biopsy specimens were graded as NASH or non-NASH. All patients underwent non-enhanced MRI including MR spectroscopy (MRS), MR elastography (MRE), and T1 mapping. Diagnostic performances of MRS, MRE, and T1 mapping for grading steatosis, activity, and fibrosis were evaluated. A multiparametric MR index combining fat fraction (FF), liver stiffness (LS) value, and T1 relaxation time was developed using linear regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of the newly devised MR index. Twenty NASH patients and 27 non-NASH patients were included. Using MRS, MRE, and T1 mapping, the mean areas under the curve (AUCs) for grading steatosis, fibrosis, and activity were 0.870, 0.951, and 0.664, respectively. The multiparametric MR index was determined as 0.037 × FF (%) + 1.4 × LS value (kPa) + 0.004 × T1 relaxation time (msec) −3.819. ROC curve analysis of the MR index revealed an AUC of 0.883. The cut-off value of 6 had a sensitivity of 80.0% and specificity of 85.2%. The multiparametric MR index combining FF, LS value, and T1 relaxation time showed high diagnostic performance for detecting NASH in NAFLD patients.
引用
收藏
相关论文
共 50 条
  • [31] Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
    Angelico, F.
    Burattin, M.
    Alessandri, C.
    Del Ben, M.
    Lirussi, F.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [32] What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
    Doumas, Michael
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios G.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (05) : 425 - 428
  • [33] The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Zhang, Chunye
    Liu, Shuai
    Yang, Ming
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (02) : 148 - 161
  • [34] Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Ahsan, Farah
    Oliveri, Federico
    Goud, Harshit K.
    Mehkari, Zainab
    Mohammed, Lubna
    Javed, Moiz
    Althwanay, Aldanah
    Rutkofsky, Ian H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [35] The importance of regular screening for HCC in non-alcoholic steatohepatitis/non-alcoholic fatty liver disease
    Keitoku, Taisei
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Ishido, Shun
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Huang, Hiroyuki Nakanishi Daniel
    Izumi., Namiki
    Red, Musashino
    JOURNAL OF HEPATOLOGY, 2023, 78 : S644 - S644
  • [36] Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review
    Mohammadi, Zahra
    Poustchi, Hossein
    Motamed-Gorji, Nazgol
    Eghtesad, Sareh
    Hekmatdoost, Azita
    Saniee, Parastoo
    Merat, Shahin
    ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (01) : 44 - 52
  • [38] Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis
    Athyros, Vasilios G.
    Katsiki, Niki
    Doumas, Michael
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (02) : 104 - 106
  • [39] A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease
    Eng, Katharine
    Lopez, Rocio
    Liccardo, Daniela
    Nobili, Valerio
    Alkhouri, Naim
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (11) : 1008 - 1013
  • [40] VALIDATION OF A NOVEL BIOMARKER MODEL FOR THE PREDICTION OF NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Tanwar, S.
    Trembling, P.
    Guha, I. N.
    Parkes, J.
    Kaye, P.
    Burt, A. D.
    Ryder, S. D.
    Aithal, G. P.
    Day, C. P.
    Rosenberg, W. M.
    GUT, 2011, 60 : A4 - A5